| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | $3.2M+504.6% | $527K+128.1% | $231K+40.0% | $165K-11.3% | $186K-98.1% | $9.6M |
| Accounts receivable, net | $22.9M+8.3% | $21.2M+6.7% | $19.8M+17.5% | $16.9M+9.5% | $15.4M+4.7% | $14.7M |
| Inventories, net | $5.4M-17.4% | $6.5M+2.0% | $6.4M+32.8% | $4.8M+22.4% | $3.9M+31.3% | $3.0M |
| Other current assets | $4.9M+22.8% | $4.0M-4.9% | $4.2M+42.3% | $2.9M+15.3% | $2.5M+5.5% | $2.4M |
| Total current assets | $36.3M+13.0% | $32.2M+5.0% | $30.6M+23.6% | $24.8M+12.3% | $22.1M-25.9% | $29.8M |
| Medical equipment for sale or rental | $4.6M+45.4% | $3.2M+3.5% | $3.0M+9.3% | $2.8M+60.2% | $1.7M+8.7% | $1.6M |
| Medical equipment in rental service, net of accumulated depreciation | $34.5M-12.0% | $39.2M+12.2% | $34.9M-11.5% | $39.5M-1.1% | $39.9M+12.0% | $35.6M |
| Property & equipment, net of accumulated depreciation | $3.4M-16.7% | $4.0M-6.7% | $4.3M-1.5% | $4.4M-3.1% | $4.5M+5.3% | $4.3M |
| Goodwill | $3.7M+0.0% | $3.7M+0.0% | $3.7M+0.0% | $3.7M+0.0% | $3.7M | $0 |
| Intangible assets, net | $6.9M+6.4% | $6.5M-13.3% | $7.4M-11.7% | $8.4M-22.8% | $10.9M-2.2% | $11.2M |
| Operating lease right of use assets | $4.2M-22.3% | $5.4M-19.8% | $6.7M+60.8% | $4.2M-1.7% | $4.2M-4.9% | $4.5M |
| Deferred income taxes | $4.6M-35.4% | $7.2M-21.1% | $9.1M-5.3% | $9.6M-4.1% | $10.0M+0.7% | $10.0M |
| Derivative financial instruments | $748K-49.5% | $1.5M+2.7% | $1.4M-26.6% | $2.0M+453.5% | $355K | — |
| Other assets | $1.7M+91.1% | $878K-44.5% | $1.6M+1876.3% | $80K-31.0% | $116K+10.5% | $105K |
| Total assets | $100.6M-2.9% | $103.6M+0.7% | $102.9M+3.5% | $99.4M+1.8% | $97.6M+0.6% | $97.0M |
| Accounts payable | $10.8M+9.9% | $9.8M+23.0% | $8.0M-4.0% | $8.3M+6.1% | $7.9M+16.0% | $6.8M |
| Other current liabilities | $9.4M+19.8% | $7.8M+1.4% | $7.7M+25.8% | $6.1M+30.8% | $4.7M-31.1% | $6.8M |
| Total current liabilities | $20.2M+14.3% | $17.7M+12.4% | $15.7M+8.6% | $14.5M+12.2% | $12.9M-43.9% | $23.0M |
| Long-term debt, net of current portion | $19.6M-17.8% | $23.9M-18.0% | $29.1M-12.2% | $33.2M+1.2% | $32.7M+11.5% | $29.4M |
| Operating lease liabilities, net of current portion | $3.4M-24.8% | $4.6M-21.4% | $5.8M+54.2% | $3.8M+2.5% | $3.7M-5.0% | $3.9M |
| Total liabilities | $43.2M-6.2% | $46.1M-8.9% | $50.6M-1.5% | $51.4M+4.2% | $49.3M-12.3% | $56.2M |
| Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued | $0 | $0 | $0 | $0 | $0 | $0 |
| Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,209,636 shares issued and outstanding as of December 31, 2025 and 21,272,351 shares issued and outstanding as of December 31, 2024 | $2K+0.0% | $2K+0.0% | $2K+0.0% | $2K+0.0% | $2K+0.0% | $2K |
| Additional paid-in capital | $117.5M+3.2% | $113.9M+3.7% | $109.8M+3.8% | $105.9M+3.9% | $101.9M+20.2% | $84.8M |
| Accumulated other comprehensive income | $565K-49.5% | $1.1M+2.8% | $1.1M-26.9% | $1.5M+455.6% | $268K | $0 |
| Retained deficit | -$60.7M-5.6% | -$57.5M+2.0% | -$58.6M+1.2% | -$59.3M-10.1% | -$53.9M-22.4% | -$44.0M |
| Total stockholders’ equity | $57.3M-0.4% | $57.5M+10.0% | $52.3M+9.0% | $48.0M-0.6% | $48.3M+18.5% | $40.8M |
| Total liabilities and stockholders’ equity | $100.6M-2.9% | $103.6M+0.7% | $102.9M+3.5% | $99.4M+1.8% | $97.6M+0.6% | $97.0M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.